Dose-ranging Study of Nemolizumab in Atopic Dermatitis
Public ClinicalTrials.gov record NCT03100344. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-blind, Multi-center, Parallel-group, Placebo-controlled Dose-ranging Study to Assess the Efficacy and Safety of Nemolizumab in Moderate-to-severe Atopic Dermatitis Subjects With Severe Pruritus Receiving Topical Corticosteroids (TCS)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Assess the efficacy of several subcutaneous doses of nemolizumab in moderate-to-severe atopic dermatitis (AD) subjects with severe pruritus receiving TCS, who were not adequately controlled with topical treatments.
Study identification
- NCT ID
- NCT03100344
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 226 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 14, 2017 (Actual)
- Primary completion
- Jul 19, 2018 (Actual)
- Completion
- Sep 21, 2018 (Actual)
- Last update posted
- Oct 22, 2019
2017 – 2018
United States locations
- U.S. sites
- 26
- U.S. states
- 14
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Investigational site | Birmingham | Alabama | 35209 | — |
| Galderma Investigational site | Fort Smith | Arkansas | 72916 | — |
| Galderma Investigational site | Beverly Hills | California | 90212 | — |
| Galderma Investigational site | Fountain Valley | California | 92708 | — |
| Galderma Investigational site | Fremont | California | 94538 | — |
| Galderma Investigational site | Rolling Hills Estates | California | 90274 | — |
| Galderma Investigational site | Santa Ana | California | 92701 | — |
| Galderma Investigational site | Santa Monica | California | 90404 | — |
| Galderma Investigational site | Miami | Florida | 33135 | — |
| Galderma Investigational site | Tampa | Florida | 33607 | — |
| Galderma Investigational Site | Tampa | Florida | 33624 | — |
| Galderma Investigational site | Columbus | Georgia | 31904 | — |
| Galderma Investigational site | Sandy Springs | Georgia | 30328 | — |
| Galderma Investigational Site | Darien | Illinois | 60561 | — |
| Galderma Investigational Site | Overland Park | Kansas | 66215 | — |
| Galderma Investigational site | New Orleans | Louisiana | 70115 | — |
| Galderma Investigational Site | Farmington Hills | Michigan | 78334 | — |
| Galderma Investigational site | Forest Hills | New York | 11375 | — |
| Galderma Investigational site | New York | New York | 10025 | — |
| Galderma Investigational Site | New York | New York | 10075 | — |
| Galderma Investigational site | Chapel Hill | North Carolina | 27516 | — |
| Galderma Investigational Site | Johnston | Rhode Island | 02919 | — |
| Galderma Investigational site | Dallas | Texas | 75230 | — |
| Galderma Investigational site | San Antonio | Texas | 78218 | — |
| Galderma Investigational Site | Waco | Texas | 76710 | — |
| Galderma Investigational site | Richmond | Virginia | 23220 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03100344, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 22, 2019 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03100344 live on ClinicalTrials.gov.